Triple

T5872822
Position Surface form Disambiguated ID Type / Status
Subject European Union pharmaceutical legislation E130557 entity
Predicate includes P1393 FINISHED
Object Regulation (EC) No 1394/2007
Regulation (EC) No 1394/2007 is the core EU legal framework governing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies, setting specific rules for their authorization, supervision, and pharmacovigilance.
E559101 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regulation (EC) No 1394/2007 | Statement: [European Union pharmaceutical legislation, includes, Regulation (EC) No 1394/2007]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Regulation (EC) No 1394/2007
Context triple: [European Union pharmaceutical legislation, includes, Regulation (EC) No 1394/2007]
  • A. Regulation (EC) No 294/2008
    Regulation (EC) No 294/2008 is the EU legislative act that established the European Institute of Innovation and Technology and set out its mission, structure, and operating framework.
  • B. Regulation (EC) No 726/2004
    Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
  • C. Regulation (EC) No 851/2004
    Regulation (EC) No 851/2004 is the EU law that established the European Centre for Disease Prevention and Control and defined its mandate, structure, and functions in coordinating infectious disease surveillance and control across member states.
  • D. Regulation (EU) No 1094/2010
    Regulation (EU) No 1094/2010 is an EU legislative act that established the European Insurance and Occupational Pensions Authority (EIOPA) and set out its powers and supervisory framework for insurance and pension markets in the European Union.
  • E. Regulation (EU) No 1093/2010
    Regulation (EU) No 1093/2010 is the EU legislative act that established the European Banking Authority and set out its mandate, powers, and governance framework for overseeing the banking sector.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Regulation (EC) No 1394/2007
Triple: [European Union pharmaceutical legislation, includes, Regulation (EC) No 1394/2007]
Generated description
Regulation (EC) No 1394/2007 is the core EU legal framework governing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies, setting specific rules for their authorization, supervision, and pharmacovigilance.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Regulation (EC) No 1394/2007
Target entity description: Regulation (EC) No 1394/2007 is the core EU legal framework governing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies, setting specific rules for their authorization, supervision, and pharmacovigilance.
  • A. Regulation (EC) No 294/2008
    Regulation (EC) No 294/2008 is the EU legislative act that established the European Institute of Innovation and Technology and set out its mission, structure, and operating framework.
  • B. Regulation (EC) No 726/2004
    Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
  • C. Regulation (EC) No 851/2004
    Regulation (EC) No 851/2004 is the EU law that established the European Centre for Disease Prevention and Control and defined its mandate, structure, and functions in coordinating infectious disease surveillance and control across member states.
  • D. Regulation (EU) No 1094/2010
    Regulation (EU) No 1094/2010 is an EU legislative act that established the European Insurance and Occupational Pensions Authority (EIOPA) and set out its powers and supervisory framework for insurance and pension markets in the European Union.
  • E. Regulation (EU) No 1093/2010
    Regulation (EU) No 1093/2010 is the EU legislative act that established the European Banking Authority and set out its mandate, powers, and governance framework for overseeing the banking sector.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0085047dc8190af24e311edad3c07 completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c035f99b788190b5b06d83b9499bfa completed March 22, 2026, 6:33 p.m.
NED1 Entity disambiguation (via context triple) batch_69c0e377e1108190b0820f92eab012c2 completed March 23, 2026, 6:53 a.m.
NEDg Description generation batch_69c0f72625888190ad23927d0962097b completed March 23, 2026, 8:17 a.m.
NED2 Entity disambiguation (via description) batch_69c0f7fb0cac8190b3b0913689c95542 completed March 23, 2026, 8:21 a.m.
Created at: March 22, 2026, 3:56 p.m.